From The Editor | January 28, 2014

Women In Bio Profile: Industry Insights From The Executive Director Of Compliance At Seattle Genetics

To access this content, please Register or Sign In.

By Ed Miseta, chief editor, Outsourced Pharma and Clinical Leader
Follow Me On Twitter @outsourcedpharm

Ed Miseta

From the time she was young, Kristin Rand’s mother said she would be an actress or a lawyer. Although she thought her mother was probably correct, she didn’t like the prospect of becoming either, merely because she did not want her mother to have predicted her future. While in high school she developed an interest in genetics and the promise it held for the future of personalized medicine. Rand notes she always had an interest in the questions that science had not yet answered.  

She began her collegiate career at Fordham University as a pre-med student but was not sure she would want to go to medical school after graduation. She opted to pursue a specialized undergraduate degree, eventually transferring to UCONN and landing on their Diagnostic Genetic Sciences Program. When she later decided to go on to graduate work, the choice was between a degree in law or molecular genetics. She chose law and finally succumbed to what her mother always felt she was naturally inclined to do. She made FDA law and bioethics the focus of her training. After working in medical communications, education, and legal for various vendor companies, she moved over to the pharma side of the house. Her first position was with Wyeth, prior to its acquisition by Pfizer. The dynamics of working in such a large and complex global organization again peaked her interest, and was the impetus for her returning to school, this time to secure a masters degree in industrial-organizational psychology.

After serving in various positions at Wyeth and Genentech, she landed at Seattle Genetics, where she currently serves as executive director of compliance.

Newsletter Signup
Newsletter Signup